Position in REPL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$50,269,068
+$32,847,907 QoQ
Shares Held
4,541,018
+99.4% QoQ
Ownership
4.82%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 199 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REPL Over Time
Shares Held
Position Value (USD)
Derivatives in REPL
reported options exposure · as of Jun 30, 2026CallValue
$110,700
CallShares
10,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $13,181,249,908 across 360 Biotechnology names. REPL ranks #65 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,481,761 | $1,232,765,138 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,163,191 | $725,296,113 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
18,556,458 | $656,713,046 | |
| 4 | TECH |
BIO-TECHNE Corp
|
7,343,324 | $518,805,838 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,133,101 | $399,487,154 | |
| 6 | MRNA |
Moderna, Inc.
|
4,671,950 | $327,176,656 | |
| 7 | TNGX |
Tango Therapeutics, Inc.
|
9,980,620 | $311,994,180 | |
| 8 | INCY |
Incyte Corp
|
2,305,782 | $261,383,446 |
All Filings in REPL
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,269,068 | 4,541,018 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $110,700 | 10,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $17,421,161 | 2,277,276 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,396,692 | 658,096 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $4,754,606 | 1,134,751 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $10,380,004 | 1,117,331 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $6,729,128 | 690,167 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $6,915,075 | 571,022 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,789,851 | 619,512 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,994,693 | 666,077 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,193,987 | 513,340 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $18,873,783 | 2,238,883 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $9,570,136 | 559,330 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $14,228,588 | 612,773 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $11,376,518 | 644,197 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $4,085,113 | 150,188 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $3,194,535 | 184,976 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $3,945,235 | 225,700 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $2,403,976 | 141,577 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,852,301 | 105,251 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $7,141,757 | 240,950 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $8,248,696 | 214,698 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $13,103,861 | 429,494 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,367,464 | 245,543 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,320,289 | 57,354 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $853,223 | 34,335 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $296,607 | 29,750 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||